Okawa Takumi, Hiraoka Hiroko, Wada Yuko, Baba Kenji, Itamoto Kazuhito, Mizuno Takuya, Okuda Masaru
Laboratories of Veterinary Internal Medicine, Department of Veterinary Medicine, Faculty of Agriculture, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan.
J Vet Med Sci. 2012 May;74(5):677-80. doi: 10.1292/jvms.11-0453. Epub 2011 Dec 27.
Second malignancies are frequent complications in human patients with chronic lymphocytic leukemia (CLL). However, the clinical details and outcome of this phenomenon were unclear in their canine counterparts. Here, we report a dog with high-grade lymphoma concurrent with T-cell CLL. A 10-year-old male golden retriever presented with lymphadenopathies. The lymph nodes contained large-sized lymphocytes, raising suspicion of high-grade lymphoma. Meanwhile, small lymphocytic lymphocytosis in the peripheral blood was consistent with CLL. Interestingly, molecular biological analyses revealed that CLL cells were of the T-cell type, whereas lymphoma cells were of the B-cell type. Chemotherapy using the L-VCA short protocol was effective for 155 days, but the dog died on day 194 after diagnosis, despite rescue therapies.
第二原发性恶性肿瘤是慢性淋巴细胞白血病(CLL)人类患者常见的并发症。然而,这种现象在犬类中的临床细节和结果尚不清楚。在此,我们报告一只患有高级别淋巴瘤并发T细胞CLL的犬。一只10岁雄性金毛猎犬出现淋巴结病。淋巴结中含有大淋巴细胞,怀疑为高级别淋巴瘤。同时,外周血中的小淋巴细胞增多与CLL一致。有趣的是,分子生物学分析显示CLL细胞为T细胞型,而淋巴瘤细胞为B细胞型。使用L-VCA短方案化疗155天有效,但尽管进行了抢救治疗,该犬在诊断后第194天死亡。